透過您的圖書館登入
IP:3.142.98.108
  • 期刊

全民健保糖尿病門診問題處方之分析-以北台灣為中心之研究

Inappropriate Prescriptions Issued to Ambulatory Diabetic Patients in National Health Insurance-A Study Based on Northern Taiwan

摘要


目標:糖尿病病患常使用多重藥物,本研究探討健保糖尿病門診病人可能存在的問題處方。方法:採次級資料分析,以健保局北區分局提供之1997年9月至1998年6月醫療院所門診申報檔,擷取符合糖尿病及糖尿病相關併發症診斷碼之病人,篩選出處方箋中有使用降血糖藥者為研究對象,計有35,981名,處方總數為333,414張,而藥品醫令總數則為17,795,911筆。結果:糖尿病門診病患研究期間換算成每年每人平均看診次數14.6次,平均門診醫療費用11,822元,其中平均藥品費用佔78.6%(9,292元);平約每處方用藥日數為18.41天,平均用藥筆數為4.1筆。在可判讀之口服降血糖藥處方中,劑量有問題之處方佔4.7%,重複用藥處方佔2.9%,處方出現重度、中度不良交互作用問題者分別佔3.02%與40.02%,整體有45.28%處方有前述三者之任一問題。以對數複回歸比較病人與不同醫院特質,其處方問題之勝算比皆有顯著差異,勝算比從診療科別的其他科1.09(95%信賴區間=1.06-1.13)到區域醫院的8.39(95%信賴區間=7.56-9.30)不等。結論:女性、年齡較大及有其他糖尿病慢性合併症的病人,出現問題處方的風險較高;醫院層級亦呈現不等程度的開立問題處方之風險,非醫學中心在超量處方開立的勝算比最高(介於3.83-8.39),相對於公立醫院,財團法人醫院勝算比為3.95(95%信賴區間=3.66-4.26),和立醫院亦達1.21(信賴區間95%=1.13-1.30)。

關鍵字

糖尿病 健保門診 問題處方

並列摘要


Objectives: Diabetic patients generally are users of multiple medications. This study explored potential inappropriate prescription problems of ambulatory diabetic patients in the National Health Insurance (NHI). Methods: This study applied secondary data analysis based on a claim database (September 1997~June 1998) provided by the Northern Branch of the NHI Bureau by selecting patients diagnosed with diabetes mellitus (DM) and DM complications ICD-9 codes. 35, 981 patients receiving hypoglycemic medications were included, and a total of 333,414 prescriptions with 17,795,911 medicines written in the prescriptions were identified. Results: The diabetic patients in this study had an average of 14.6 ambulatory visits per year, with average medical expenses of NT$11,822, 78.6% (NT$9,292) attributable to pharmaceuticals. The average days per prescription were 18.41 days, and there were 4.1 drugs per prescription. In the valid prescriptions, 4.7% of prescriptions had over-dosage problems, while 2.9% of prescriptions had duplicated hypoglycemic medication. Besides, 40.02% had moderate and 3.02% had severe adverse drug interactions. Overall, there were 45.28% of prescriptions that had one or more kinds of problem prescriptions. After controlling the patient characteristics and types of providers, there was statistical significance in term of odds ratio in written inappropriate prescriptions. The odds ratio varied from 1.09 (95% CI=1.06-1.13) of the other clinical departments versus family medicine to 8.39 (95% CI=7.56-9.30) of metropolitan hospital versus academic medical center. Prescriptions with over-dosage were more likely found among hospitals and clinics than academic medical centers with odds ratios ranging from 3.83 to 8.39. Comparing with public hospitals, the odds ratios were 3.93 (95% CI=3.66-4.26) for non-proprietary hospitals and 1.21 (95% CI=1.13-1.30) for private hospitals. Conclusions: The odds ratio of patients who receive inappropriate prescriptions were higher for females, patients with older age, and patients with DM complications. There were also various risks among different types of providers.

參考文獻


American Diabetes Association(1998).Economic consequences of diabetes mellitus in the U.S.Diabetes Care.21,296-308.
Chen SF,Hsu HH,Lee HS,Lin CS,Chou YC,Tien JH(2004).Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan.J Clin Pharm Ther.29,547-58.
Lin T,Chou P,Lai MS,Tsai ST,Tai TY(2001).Direct Cost of-illness of patients with Diabetes Mellitus in Taiwan.Diabetes Res Clin Pr.54,43-6.
McGulloch DK,Galsgow RE,Hampson SE,Wagner E(1994).A systematic approach to diabetes management in the post-DCCT era.Diabetes Care.17,765-9.

被引用紀錄


吳培滋(2007)。影響醫學中心醫師開立慢性病連續處方箋之因素探討〔碩士論文,長榮大學〕。華藝線上圖書館。https://doi.org/10.6833/CJCU.2007.00088
吳亭儀(2015)。不同專科別對糖尿病腎病變照護結果差異性之探討-以照護行為為中介變項〔碩士論文,義守大學〕。華藝線上圖書館。https://doi.org/10.6343/ISU.2015.00171
郭昱君(2016)。醫院門診處方警示系統採用情形與不適當處方之相關探討〔博士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201610205
陳舒亭(2013)。台灣糖尿病人初次口服降血糖之處方品質探討〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2013.01734
蘇浩然(2011)。健保藥價調整在不同藥品市場競爭特質下對於處方型態之影響:以口服降血糖用藥長期分析〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.00692

延伸閱讀